Lily Lu

5.8k total citations · 2 hit papers
25 papers, 2.8k citations indexed

About

Lily Lu is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Lily Lu has authored 25 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 11 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Lily Lu's work include CAR-T cell therapy research (6 papers), Immune cells in cancer (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Lily Lu is often cited by papers focused on CAR-T cell therapy research (6 papers), Immune cells in cancer (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Lily Lu collaborates with scholars based in United States, Canada and Austria. Lily Lu's co-authors include Dmitry I. Gabrilovich, Je-In Youn, Matthew J. Cotter, Judith C. McCaffrey, Hyun-Il Cho, Thomas V. McCaffrey, Cesar A. Corzo, Pingyan Cheng, Esteban Celis and Thomas Condamine and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Lily Lu

24 papers receiving 2.7k citations

Hit Papers

HIF-1α regulates function and differentiation of myeloid-... 2010 2026 2015 2020 2010 2019 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment
    2010 930 citations Lily Lu, Matthew J. Cotter et al. profile →
  2. Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor–transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma
    2019 301 citations Stephanie L. Goff, Richard A. Morgan et al. Journal of Immunotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lily Lu United States 17 1.6k 931 557 468 306 25 2.8k
Nour-Eddine Rhaleb United States 32 490 0.3× 371 0.4× 888 1.6× 162 0.3× 118 0.4× 43 2.7k
Takashi Shichita Japan 28 1.9k 1.2× 392 0.4× 1.6k 2.8× 77 0.2× 218 0.7× 51 4.3k
Linda S. Higgins United States 34 395 0.3× 1.1k 1.2× 2.1k 3.8× 315 0.7× 333 1.1× 66 4.0k
Jing Xue China 31 819 0.5× 950 1.0× 1.1k 2.0× 121 0.3× 331 1.1× 77 3.0k
Graziano Pelli Switzerland 32 1.5k 0.9× 624 0.7× 1.1k 1.9× 593 1.3× 227 0.7× 52 3.5k
Hua Zhu China 25 576 0.4× 219 0.2× 1.0k 1.8× 80 0.2× 481 1.6× 92 2.5k
Julia J. Inglis United Kingdom 22 804 0.5× 314 0.3× 594 1.1× 318 0.7× 184 0.6× 27 2.4k
Alex Agrotis Australia 35 1.3k 0.8× 165 0.2× 1.2k 2.1× 96 0.2× 320 1.0× 62 3.3k
Sergey Ryzhov United States 27 832 0.5× 451 0.5× 1.2k 2.1× 67 0.1× 203 0.7× 60 3.0k
Julia Kargl Austria 28 1.1k 0.7× 886 1.0× 958 1.7× 707 1.5× 284 0.9× 62 3.0k

Countries citing papers authored by Lily Lu

Since Specialization
Citations

This map shows the geographic impact of Lily Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lily Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lily Lu more than expected).

Fields of papers citing papers by Lily Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lily Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lily Lu. The network helps show where Lily Lu may publish in the future.

Co-authorship network of co-authors of Lily Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Lily Lu. A scholar is included among the top collaborators of Lily Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lily Lu. Lily Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tomescu, Costin, et al.. (2025). Gene-modified NK cells expressing CD64 and preloaded with HIV-specific BNAbs target autologous HIV-1–infected CD4+ T cells by ADCC. The Journal of Immunology. 214(2). 253–264. 1 indexed citations
2.
3.
Lu, Lily & Joseph M. Salvino. (2022). The In-Cell Western immunofluorescence assay to monitor PROTAC mediated protein degradation. Methods in enzymology on CD-ROM/Methods in enzymology. 681. 115–153. 1 indexed citations
4.
Goff, Stephanie L., Richard A. Morgan, James C. Yang, et al.. (2019). Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor–transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma. Journal of Immunotherapy. 42(4). 126–135. 301 indexed citations breakdown →
5.
Assadipour, Yasmine, Nikolaos Zacharakis, Jessica S. Crystal, et al.. (2017). Characterization of an Immunogenic Mutation in a Patient with Metastatic Triple-Negative Breast Cancer. Clinical Cancer Research. 23(15). 4347–4353. 28 indexed citations
6.
Noone, Damien, Magdalena Riedl, Fred G. Pluthero, et al.. (2016). Von Willebrand factor regulates complement on endothelial cells. Kidney International. 90(1). 123–134. 49 indexed citations
7.
Lowe, Emily, Arianne Perez, Steven A. Rosenberg, et al.. (2016). Abstract 2305: Comparative evaluation of peripheral blood T cells and resultant engineered anti-CD19 CAR T cell products from relapsed/refractory non-Hodgkin's lymphoma (NHL) patients. Cancer Research. 76(14_Supplement). 2305–2305. 1 indexed citations
8.
Kochenderfer, James N., Robert Somerville, Lily Lu, et al.. (2014). Anti-CD19 CAR T Cells Administered after Low-Dose Chemotherapy Can Induce Remissions of Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma. Blood. 124(21). 550–550. 23 indexed citations
9.
Jodele, Sonata, Tsuyoshi Fukuda, Alexander A. Vinks, et al.. (2013). Eculizumab Therapy in Children with Severe Hematopoietic Stem Cell Transplantation–Associated Thrombotic Microangiopathy. Biology of Blood and Marrow Transplantation. 20(4). 518–525. 169 indexed citations
10.
11.
Jodele, Sonata, Christoph Licht, Jens Goebel, et al.. (2013). Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy. Blood. 122(12). 2003–2007. 174 indexed citations
12.
Seavey, Matthew M., et al.. (2012). Therapeutic Efficacy of CEP-33779, a Novel Selective JAK2 Inhibitor, in a Mouse Model of Colitis-Induced Colorectal Cancer. Molecular Cancer Therapeutics. 11(4). 984–993. 33 indexed citations
13.
Seavey, Matthew M., et al.. (2011). Novel, orally active, proteasome inhibitor, delanzomib (CEP-18770), ameliorates disease symptoms and glomerulonephritis in two preclinical mouse models of SLE. International Immunopharmacology. 12(1). 257–270. 53 indexed citations
14.
Lu, Lily, Paweł Dobrzański, Cynthia Serdikoff, et al.. (2011). A highly selective, orally active inhibitor of Janus kinase 2, CEP-33779, ablates disease in two mouse models of rheumatoid arthritis. Arthritis Research & Therapy. 13(2). R68–R68. 65 indexed citations
15.
Seavey, Matthew M., et al.. (2011). Animal Models of Systemic Lupus Erythematosus (SLE) and Ex Vivo Assay Design for Drug Discovery. Current Protocols in Pharmacology. 53(1). Unit 5.60–Unit 5.60. 14 indexed citations
16.
Nagaraj, Srinivas, Je-In Youn, Hannah Weber, et al.. (2010). Anti-inflammatory Triterpenoid Blocks Immune Suppressive Function of MDSCs and Improves Immune Response in Cancer. Clinical Cancer Research. 16(6). 1812–1823. 225 indexed citations
17.
18.
Schaffhauser, Hervé, Joanne R. Mathiasen, Amy DiCamillo, et al.. (2009). Dimebolin is a 5-HT6 antagonist with acute cognition enhancing activities. Biochemical Pharmacology. 78(8). 1035–1042. 53 indexed citations
19.
Klein, Thomas, Cathy Newton, Kellie Larsen, et al.. (2003). Cannabinoid receptors and T helper cells. Journal of Neuroimmunology. 147(1-2). 91–94. 69 indexed citations
20.
Todeva, Emanuela & Lily Lu. (2001). The Petrochemical Industry in China - Government Regulation and Development Policies. SSRN Electronic Journal. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nour-Eddine Rhaleb Breakdown of academic impact, for papers by Takashi Shichita Breakdown of academic impact, for papers by Linda S. Higgins Breakdown of academic impact, for papers by Jing Xue Breakdown of academic impact, for papers by Graziano Pelli Breakdown of academic impact, for papers by Hua Zhu Breakdown of academic impact, for papers by Julia J. Inglis Breakdown of academic impact, for papers by Alex Agrotis Breakdown of academic impact, for papers by Sergey Ryzhov Breakdown of academic impact, for papers by Julia Kargl
Rankless by CCL
2026